GlassScriptPhysician profile
Muhammad Sattar
NPI 1679925408
$760.42
in general payments reported to CMS, 2019-2025
11 companies · $80.85 in 2025
The $80.85 reported for 2025 was less than what a typical Hospitalist provider received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $185 · 2022: $55.64 · 2023: $265 · 2024: $175 · 2025: $80.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $520.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $520.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $296.81 | 2022-2025 | Dalvance, Teflaro |
| Astellas Pharma US INC | $159.98 | 2019 | |
| Janssen Pharmaceuticals, INC | $106.28 | 2022-2024 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $37.20 | 2024 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $31.93 | 2023 | Fasenra, Brilinta |
| Eisai INC. | $24.72 | 2019 | |
| Merck Sharp & Dohme LLC | $24.04 | 2025 | Bridion |
| Abbott Laboratories | $21.63 | 2024 | Amplatzer Amulet |
| Inari Medical, INC. | $20.75 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Pfizer INC. | $19.60 | 2025 | |
| Viatris Specialty LLC | $17.48 | 2025 | Yupelri |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Sattar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.